Aflac's 'Hold' Rating Reiterated by Keefe, Bruyette & Woods

Analysts maintain neutral outlook on insurance provider's stock performance

Mar. 29, 2026 at 6:08am

Got story updates? Submit your updates here. ›

Keefe, Bruyette & Woods has reissued a 'hold' rating on shares of Aflac (NYSE: AFL), the insurance provider based in Columbus, Georgia. The analysts have set a $113 price target on the stock, citing a neutral outlook on the company's financial performance and growth prospects.

Why it matters

Aflac is a major player in the supplemental insurance market, offering products that help policyholders manage out-of-pocket healthcare costs. The company's stock performance and analyst ratings are closely watched by investors as indicators of its financial health and competitive positioning.

The details

In their research note, the Keefe, Bruyette & Woods analysts reiterated their 'hold' recommendation on Aflac, citing the company's mixed financial results and uncertain growth outlook. While some other analysts have issued more bullish ratings and price targets on Aflac, the Keefe, Bruyette & Woods team believes the stock is fairly valued at current levels and does not warrant a 'buy' recommendation.

  • Keefe, Bruyette & Woods issued the research note on Thursday, March 29, 2026.
  • Aflac last reported quarterly earnings on Wednesday, February 4, 2026.

The players

Aflac

A provider of supplemental insurance products based in Columbus, Georgia, offering policies that help policyholders manage out-of-pocket healthcare costs.

Keefe, Bruyette & Woods

A financial services firm that provides investment banking, asset management, and research services, including equity research coverage of Aflac.

Got photos? Submit your photos here. ›

What’s next

Investors will be closely watching Aflac's future financial results and any updates to analyst ratings and price targets to gauge the company's performance and outlook.

The takeaway

Aflac's 'hold' rating from Keefe, Bruyette & Woods reflects a neutral outlook on the insurance provider's near-term prospects, despite some more bullish views from other analysts. This highlights the mixed perspectives on Aflac's growth potential and the need for the company to demonstrate consistent financial execution to win over the investment community.